Status:
COMPLETED
Lleida TIA Intervention Study
Lead Sponsor:
Institut de Recerca Biomèdica de Lleida
Conditions:
Transient Ischemic Attack
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Having a transient ischemic attack (TIA) or a minor stroke is a real risk factor not only for early recurrent stroke but also for major extracranial vascular events. Despite these warning events provi...
Eligibility Criteria
Inclusion
- Patients with transient ischemic attack (reversible episode of neurological deficit of ischemic origin that resolved completely within 24 hours) or minor stroke (established neurological deficit of ischemic origin with US National Institutes of Health stroke scale \[NIHSS\]score of 3 or less at the time of randomization)
- All subjects will be clinically evaluated by a stroke neurologist
- All subjects will be evaluated with CT scan or MRI to exclude other causes of neurological symptoms different than brain ischemia
- Patients with independence: modified Rankin score\<3
- Patients with a critical carotid stenosis will be included after revascularization therapy
- Written informed consent
Exclusion
- Having serious comorbidities: dementia, advanced Cancer, excessive intake of alcohol (\> 280 gr/week), severe renal or hepatic insufficiency and severe cardiac failure
- Currently receiving an investigational drug or device
- Age\<18 years
- Patient or family declining to take part
- Pregnant or breastfeeding
- Transient neurological deficit for \< 5 minutes
Key Trial Info
Start Date :
March 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04524078
Start Date
March 1 2011
End Date
March 31 2020
Last Update
August 24 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.